Niki BioSolutions NIKI Ratios (2017-2025)

NASDAQ NIKI
$8.58 +0.38 (+4.63%)
At close: Aug 21, 2026 · 4:00 PM EDT
Ratios Dec2017 Dec2018 Jun2019 Dec2019 Apr2020 Jun2020 Dec2020 Jun2021 Dec2021 Jun2022 Dec2022 Jun2023 Dec2023 May2024 Aug2024 Nov2024 May2025 Aug2025 Nov2025
Profitability
Gross Margin (Quarter) 71.80%107.30%
EBT Margin (Quarter) -81.52%-43.33%-316.28%-207.58%
EBIT Margin (Quarter) -71.86%-35.35%-199.00%228.04%
EBITDA Margin (Quarter) -71.86%-35.35%-199.00%228.04%
Operating Margin (Quarter) -71.86%-35.35%-199.00%228.04%
Net Margin (Quarter) 566.78%-84.41%-45.41%-257.77%-728.61%
FCF Margin (Quarter) 1,530.74%-28.99%-36.46%-57.01%27.41%
Efficiency
Inventory Average (Quarter) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Assets Average (Quarter) 0.04B0.03B0.02B0.03B0.04B0.03B0.02B0.02B0.02B0.02B0.01B0.00B0.00B
Invested Capital (Quarter) 0.00B0.01B0.00B47.48B0.00B0.00B0.00B0.00B0.00B0.00B
Asset Utilization Ratio (Quarter) 0.551.29
Leverage & Solvency
Interest Coverage Ratio (Quarter) -7.44-4.431.40-2.30-4.28
Debt Ratio (Quarter) 0.020.300.000.000.000.000.000.120.14
Times Interest Earned (Quarter) -7.44-4.431.40-2.30-4.28
Dividends & Payouts
FCF Payout Ratio (Quarter) -1.81-0.17
Valuation
Enterprise Value (Quarter) -0.02B-0.03B-0.03B-0.01B-6.33-0.01B-0.04B-0.03B-0.01B-0.01B-0.02B-0.01B-0.01B-0.00B-0.00B-0.00B-0.00B
Return Ratios
Return on Sales (Quarter) -0.01%0.00%-0.02%-0.02%
Return on Capital Employed (Quarter) -160.57%-64.01%
Return on Assets (Quarter) -0.01%0.00%